Preferred Label : voxilaprevir;
UNII : 0570F37359;
Origin ID : C000619503;
UMLS CUI : C4507236;
ATC code(s)
Currated CISMeF NLP mapping
MeSH term(s) associated for indexing
Record concept(s)
See also inter- (CISMeF)
Semantic type(s)
https://www.has-sante.fr/jcms/p_3152658/fr/vosevi
2020
false
false
false
France
sofosbuvir, velpatasvir and voxilaprevir
drug combinations
Sofosbuvir
velpatasvir
voxilaprevir
adult
administration, oral
treatment outcome
insurance, health, reimbursement
hepatitis C, chronic
antiviral agents
evaluation of the transparency committee
carbamates
Heterocyclic Compounds, 4 or More Rings
sulfonamides
macrocyclic compounds
sofosbuvir velpatasvir voxilaprevir drug combination
---
https://www.ema.europa.eu/medicines/human/EPAR/Vosevi
2017
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
sulfonamides
sulfonamides
macrocyclic compounds
macrocyclic compounds
Sofosbuvir
velpatasvir
carbamates
Heterocyclic Compounds, 4 or More Rings
drug approval
europe
treatment outcome
product surveillance, postmarketing
administration, oral
hepatitis C, chronic
antiviral agents
antiviral agents
adult
drug interactions
pregnancy
breast feeding
NS-5 protein, hepatitis C virus
NS-5a protein, hepatitis C virus
Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action (substance)
viral nonstructural proteins
serine proteases
drug evaluation, preclinical
sofosbuvir, velpatasvir and voxilaprevir
voxilaprevir
voxilaprevir
NS3-4A serine protease, Hepatitis C virus
Sofosbuvir
velpatasvir
carbamates
Heterocyclic Compounds, 4 or More Rings
drug combinations
sofosbuvir velpatasvir voxilaprevir drug combination
---
https://www.has-sante.fr/portail/jcms/c_2817995/fr/vosevi
2017
false
false
false
France
French
sulfonamides
sulfonamides
macrocyclic compounds
macrocyclic compounds
Sofosbuvir
velpatasvir
carbamates
Heterocyclic Compounds, 4 or More Rings
treatment outcome
administration, oral
hepatitis C, chronic
antiviral agents
antiviral agents
adult
NS-5 protein, hepatitis C virus
NS-5a protein, hepatitis C virus
Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action (substance)
viral nonstructural proteins
serine proteases
insurance, health, reimbursement
evaluation of the transparency committee
sofosbuvir, velpatasvir and voxilaprevir
voxilaprevir
voxilaprevir
Sofosbuvir
velpatasvir
carbamates
Heterocyclic Compounds, 4 or More Rings
drug combinations
sofosbuvir velpatasvir voxilaprevir drug combination
---